Disclaimer: This article was published in 2019 and reflects the information available at that time.
  Pharmacists breaching regulations involving opioid replacement therapy (ORT) are quickly referred to the regulators. A recent blitz from NSW Health against pharmacies that provide opioid-replacement services is resulting in members of PDL seeking support in handling regulator inquiries. Penalties such as restrictions on practice for pharmacy owners and employed pharmacists may be involved. These incidents highlight the importance of adhering to current State-based legislation when dealing with all S8 medications, including ORT products such as methadone syrup, Subu…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

Cover for partnered charting and prescribing activities
24 November 2025
NationalProfessional activitiesPharmacist prescribing
Learn more
Is this the right jab? A vaccination service reminder
20 November 2025
NationalDispensingProfessional activitiesVaccination
Learn more
2024-2025 most reported medicines
8 October 2025
National
Learn more